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Introduction
Rectal cancer surgery often resuls in a permanent 
colostomy, and therefore seriously limited the quality 
of  life of  patients for bowel and sexual function[1, 2]. 
Therefore, it is important to assess rectal cancer patients’ 
quality of  life to determine whether such impairments 
disrupt everyday life. 
Both the cross-sectional and prospective studies of  
the QOL in rectal cancer patients with permanent 
colostomy had been shown in some countries with the 
comprehensive methods which had made reliability, 
validity and comparable results[3-5]. In China, 
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however, there were only some preliminary studies 
in this field, the majority of  which were the cross- 
sectional[6]. Besides, the trends of  the QOL of  the 
patients differed significantly among different areas. 
The aim of  this study was to establish the pattern of  
dynamic changes of  the QOL in rectal cancer patients 
with permanent colostomy by using the EORTC QLQ-
C30 and QLQ-CR38 questionnaires, so as to provide 
the basis for developing the health education program.
Materials and methods
Patients
From April to October 2011, 51 patients with cancer of  
the rectum were considered to be eligible for our study 
since they had been scheduled for Miles operation, 
agreed to participate, had no other complications and 
difficulty with communicating with each other; and 50 
people who had undergone low anterior resection (LAR), 
as control group. All the patients received postoperative 
chemotherapy FOLFOX Regimen (5- fluorouracil with 
leucovorin and oxaliplatin).
Research tools
The questionnaires were divided into two main 
sections: the European Organization for Research and 
Treatment of  Cancer QLQ-C30 and QLQ-CR38, which 
incorporating a global health and quality-of-life scale, 
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Objectives: To observe the quality of  life (QOL) in rectal cancer patients with permanent colostomy in different periods 
after operation. 
Methods: A 1-,3-,6-month prospective study of  QOL in 51 rectal cancer patients with permanent colostomy and 50 
without permanent colostomy was assessed using European Organization for Research and Treatment of  Cancer (EORTC) 
QOL-30 and CR38 questionnaires. 
Results:  The variation of  QOL in different periods was “v” type. In the 1st postoperative month, these patients had the 
lowest quality of  life scores, accompanied significantly varied functions and severe symptoms. Almost of  all indexes of  these 
patients had improved consistently in the postoperative period. The scores of  global QOL even better than pre-operative 
level at 6th months post-operation, but the social function, body image, chemotherapy side effects and financial difficulties 
had not restored to the baseline level. Patients without permanent colostomy had a better score in most of  categories of  
QOL-30 and CR38. 
Conclusions:  The 1st postoperative month was crucial for patients’ recovery, in which we should pay great attention to 
these problems which relate to the recovery of  rectal cancer patients with permanent colostomy.
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nine functional scales, ten symptom scales and seven 
single-item measures[7-9]. The responses were linearly 
transformed to provide ranges from 0 to 100. A high 
overall and function score indicated a good function, 
whereas a high symptom and single-item score indicated 
a high degree of  symptom. The study was authorized by 
EORTC and it also provided us the normal reference 
data from the “questionnaire reference data manual”. 
Scoring was according to EORTC QLQ-C30 Scoring 
Manual. 
Data collection 
From April 2011 to February 2012, after we had 
explained our study to the patients in a standard way and 
they had agreed to participate it, we collected the data 
at the time of  pre-operation and 1st, 3rd, 6th months 
post-operation through calling the patients randomly, 
respectively. 
Statistical analysis
The original data was entered into database using 
Epidata-3.0 and was analyzed using SPSS version 17.0 
with descriptive analysis, repeatable deviation analysis, 
LSD-t test and single-sample t-test. A P-value ≤0.05 
was considered statistically significant.
Results
General demographic characteristics
There were 51 permanent colostomy patients and 50 
ones without permanent colostomy participated in our 
study in all. 49 permanent colostomy patients (96.08%) 
and all 50 ones (100.0%) without permanent colostomy 
completed all the questionnaires. One had lost to follow 
up at the time of  3rd months post-operation. One had 
died within 6 months after the operation. The general 
demographic characteristics of  patients with or without 
permanent colostomy were as follows (Table 1):
The QOL of  rectal cancer patients with or without permanent 
colostomy
Table 2 reported the mean scores and statistical analysis 
of  the functional and symptom scales of  the QLQ30 
and CR38 in all patients with or without permanent 
colostomy. Through using the repeated measures 
ANOVA, the result showed that except for constipation 
and diarrhea, there was a significant difference among 
all the dimensions in patients with permanent colostomy 
(including the global QOL score). 
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Table 1 The general demographic characteristics of  permanent colostomy patients of  rectal cancer (n=49)
variables                                n                %
Gender  
Male                                            31              63.3
Female                                            18              36.7
Age  
≤44                                             6              12.2
45～59                                             22              44.9
≥60                                             21              42.9
Marriage  
Not married                                 0              0.0
Married                                             49            100.0
Education  
≤6 years schooling                   14             28.6
6-9 years schooling                   17             34.7
9-12 years schooling                    8             16.3
≥12 years schooling                   10             20.4
Family income per month  
≤699                                              11            22.4
700～1499                                 12            30.6
1500～2999                                 15            24.5
≥3000                                              11            22.4
Employment  
Employed                                 28            57.1
Not working                                 21            42.9
Fee source  
Medical insurance                    24            49.0
Farmers’ insurance                    24            49.0
At patients’ own expense                    1             2.0
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QLQ-C30      preoperative       1st postoperative    3rd postoperative      6th postoperative       F            P
 CR38                                                month               month                           month               value     value 
                                                                                      
Function scale                                                                                                                            135.3
Physical function   87.35±13.14       46.67±14.91            70.48±11.39            84.76±8.39       1          0.00
Role
function                 77.89±23.42        26.19±15.59            52.38±16.67           73.97±14.50     95.92    0.00
Emotional   
function                 68.20±16.64        35.72±19.91            61.90±18.56           73.98±14.50     51.01    0.00 
Cognitive
function                 88.42±15.03        71.42±16.67            81.29±15.07           91.54±10.66     21.46    0.00 
Social
function                 81.29±18.83        30.95±15.96            52.72±17.13           64.28±11.28     82.38    0.00 
Body image           97.96±8.69bcd      53.29±19.51acd          66.21±15.04ab         66.67±14.70ab   88.78    0.00 
Future
perspective            61.90±23.57       31.29±18.52             51.70±18.08           58.50±16.00     28.17     0.00
Global 
health and
quality-of-lif  e      71.77±13.16bcd     28.70±11.92 acd         54.42±10.31abd      74.21±10.17 abc      198.9   0.00
score Symptom                                                                                                                               5
scale
fatigue                  24.04±17.70b        52.38±18.90acd        30.16±12.83bd        21.09±13.22bc        46.92   0.00 
Nausea and                            
vomiting              5.44±13.70           15.30±20.90           21.70±18.70          10.90±16.90          3.26       0.03 
Pain                     18.40±17.20bcd       61.70±19.70acd       29.93±18.94abd       11.11±16.17abc        8.61       0.00
Problems 
with urination      4.54±11.77bc          39.91±24.94acd      18.14±17.23abd         8.90±14.79bc         48.79      0.00
Chemothera py 
side effects          5.44±11.81bcd         14.74±15.77ac        22.22±16.35abd        14.06±15.35ac       13.25      0.00
Gastrointest inal  11.29±10.38bd       31.97±14.33acd        14.69±10.45bd         4.76±6.94abc          69.48      0.00
symptoms
Stoma




QLQ-C30       preoperative         1st postoperative        3rd postoperative      6th postoperative     F           P
CR38                                                 month                        month                             month           value    value 
Shortness of
 breath           16.40±18.00             29.90±19.50               19.73±16.55              12.24±16.24         10.18     0.00
 Agrypnia      21.09±21.19bc           60.54±25.16acd            40.14±26.33abd            20.41±17.76bc       38.94      0.00 
Appetite
loss                19.05±20.41              34.01±24.99              27.21±17.57               15.65±21.63         9.09       0.00
Constipation  23.13±31.13              16.32±20.55             10.26±16.75                17.61±20.23         0.76       0.59
Diarrhea         29.90±28.90              23.10±18.30             27.23±21.75                30.19±20.30        1.16       0.33
                       22.40±19.40bcd            59.20±22.80a            59.86±22.54a                 53.74±22.37a       50.90     0.00
Weight loss     38.77±22.90bcd           19.72±25.38acd          2.72±9.22ab                   0.68±4.72ab          50.92      0.00
* Note: aP<0.05 vs the dimensions of  the pre-operation; bP<0.05 vs dimensions of  the 1st postoperative month;
cP<0.05 vs dimensions of  the 3rd postoperative month; dP<0.05 vs dimensions of  the 6th postoperative month. 
The result of  LSD-T test is as follows:
Our studies illustrated that the trend of  QOL of  
49 patients with permanent colostomy was a “v” 
type over time. In the domain of  function scale and 
global QOL in patients with permanent colostomy, 
the scores of  all items in the 1st postoperative month 
were particularly lower than any other periods of  pre 
and post operation (P<0.05). The scores of  function 
scales appeared to up-regulated and stable during the 
6 months following surgery, even approached those 
of  pre-operation. Likewise, the scores of  symptom 
scales were similar to function ones. Except for nausea, 
vomiting and chemotherapy side effects, the scores 
of  other items in the 1st postoperative month were 
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Table 3    Comparison of  quality of  life of  permanent colostomy patients with rectal cancer with normal reference data of  EORTC 
QLQ-C30～n=49～ X ±s～
                              Normal
EORTC                 reference           Pre-operation            1st postoperative             3rd postoperative         6th postoperative
QLQ-C30                data (n=1773)                                                  month                             month                            month 
Functional 
dimension 
Physical                  79.2±21.1         87.35±13.14**              46.67±14.91**              70.48±11.39**               84.76±8.39**
function 
Role                         70.4±32.8         77.89±23.42**              26.19±15.59**              52.38±16.67**                73.97±14.50
function Emotional  68.9±24.4          68.20±16.64                35.72±19.91**              61.90±18.56**               73.98±14.50*
function Cognitive   85.2±20.4          88.42±15.03               71.42±16.67**               81.29±15.07                   91.54±10.66**
function Social        76.0±28.6          81.29±18.83*               30.95±15.96**              52.72±17.13**              64.28±11.28** 
function
Global QOL            60.7±23.4         71.77±13.16**              28.70±11.92**              54.42±10.31**              74.21±10.17**
Symptom dimension
Fatigue                    34.7±28.4         24.04±17.70**              52.38±18.90**               30.16±12.83*               21.09±13.22**
Nausea and 
vomiting                 7.3±17.2             5.44±13.70                   15.30±20.90**              21.70±18.70**             10.90±16.90 
Pain                        24.0±29.6          18.40±17.20*               61.70±19.70**               29.93±18.94*               11.11±16.17**
Singe-item scale Shortness of  
breath                     17.4±26.3           16.40±18.00                29.90±19.50**                19.73±16.55               12.24±16.24* 
Agrypnia                30.5±32.6           21.09±21.19**            60.54±25.16**               40.14±26.33*               20.41±17.76**
Appetite 
loss                         19.1±30.2          19.05±20.41                 34.01±24.99**               27.21±17.57**            15.65±21.63 
Constipation           15.8±27.9          23.13±31.13*               16.32±20.55                   10.26±16.75               17.61±20.23
Diarrhea                  16.6±27.6         29.90±28.90**              23.10±18.30                  27.23±21.75**            30.19±20.30**
Financial 
difficulties          13.6±26.3    22.40±19.40**        59.20±22.80**        59.86±22.54**      53.74±22.37** 
Note:  *P<0.05  vs  normal reference data;   **P<0.01  vs  normal reference data. 
significantly higher than any other periods of  pre 
and post operation(P<0.05). The symptom scores of  
nausea and vomiting and chemotherapy side effects 
were significantly higher at the time of  3rd months 
post-operation (P<0.05). The score of  single-item scale, 
however, seem to appear different to function scale and 
symptom scale. For the items of  shortness of  breath, 
agrypnia and appetite loss, their scores were highest in 
all periods and got down-regulated at the 3rd and 6th 
postoperative month, even better than pre-operation 
(P<0.05). For the domain of  financial difficulties, there 
were meaningful differences between pre-operation 
and post-operation, whereas there were no meaningful 
differences in different periods after operation (P>0.05). 
Before operation, the score of  weight loss was bad 
and this appeared to get better during the 6 months 
following surgery (P<0.05). Except for the categories 
of  nausea and vomiting, gastrointestinal symptoms, 
appetite loss, financial difficulties and weight loss, there 
were significantly better scores in most of  categories 
of  QOL-30 and CR38 in patients without permanent 
colostomy than that in patients with permanent 
colostomy(P<0.05) (Table 2).
Before the operation, the scores of  patients’ 
physical function, role function, social function, global 
QOL, constipation, diarrhea and financial difficulties 
in patients with permanent colostomy were obviously 
higher than the norm, whereas the scores of  fatigue, 
pain and agrypnia were lower than the norm (P<0.05). 
At the one-month time point post operation, the scores 
of  all the function scale (including the global QOL), 
symptom scales and single-item scale were obviously 
worse than the norm(P<0.05). There was a trend toward 
better scores for global health and QOL scale in rectal 
cancer patients with permanent colostomy. Although 
the scores of  all the functional dimensions, which except 
the cognitive function and include the global QOL 
and fatigue, were lower than the norm; and the scores 
of  nausea and vomiting, pain, agrypnia, appetite loss, 
diarrhea and financial difficulties were higher than the 
norm (P<0.05). But this status had got better at post-
operative 3 months. Except for social function, diarrhea 
and financial difficulties, all items of  EORTC QLQ-
C30 had recovered.  Especially, the scores of  fatigue, 
pain, shortness of  breath, agrypnia, physical function, 
emotional function, cognitive function and global QOL 
were better than the norm (P<0.05) (Table 3).
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The anxieties of  rectal cancer patients with permanent colostomy 
Whether the operation can be successful is the most 
anxious thing for the patients to worry about before 
operation. When these patients had got surgery, the 
patients’ anxiety had changed to the recurrence after the 
operation and accompanied by sacrococcygeal region 
wound, stoma complication in the 1st postoperative 
month and defecation problem, stoma complication in 
the 3rd and 6th month. (Table 4)
Table 4    The anxieties of  permanent colostomy patients with rectal cancer in different operative periods～n=49～ 
Anxiety of        Pre-operation                     1st postoperative      3rd postoperative      6th postoperative 
patients                                                                month                    month                       month  
                   
     n                 %              n                %              n                  %                n                   % 
Possibility of  
successful        25              51.0          0                  0.0           0                   0.0             0             0.0
operation 
Financial 
ability              13             26.5          2                   4.1           3                   6.1             5            10.2 
protopathy        8             16.3         14                 28.6          15                30.6           17           34.7
Defecation        3             6.1           2                    4.1          14                 28.6           15           30.6
problem 
Sacrococcygeal 
region wound    0            0.0           12                  24.5          4                  8.2             2             4.1
Micturition        0            0.0           7                    14.3          2                  4.1             1             2.0
Stoma 
complication      -              -            11                   22.4         11                 22.4            9            18.4
Abdomen 
wound                0            0.0           1                    2.0           0                   0.0             0             0
 
The incidence rate and types of  stoma complications 
twenty four patients suffered from the stoma 
complications in the 1st postoperative month (48.98%), 
23 in the 3rd postoperative month (46.94%) and 20 
in the 6th postoperative month (40.82%). Table 5 
illustrated the types. 
Table 5 The incidence rate and types of  stoma complications of  permanent colostomy patients with rectal cancer in different operative 
periods (n=49) 
                                            
                                              1st postoperative                 3rd postoperative                        6th postoperative
Types of  stoma 
complications                              month                                     month                                      month 
                                            n                     %                       n                    %                       n                     %
Peristomal 
dermatitis                            14                28.57                   14                28.57                     8                16.33
Peristomal mucous




mucous membrane              2               4.08                2               4.08                 0               0.00
separation




herniation                      2              4.08                5              10.20                11              22.5 
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Discussion
The purpose of  this study was to provide a comprehensive 
overview of  the functional outcome and quality of  life 
in rectal cancer patients with permanent colostomy. 
The Camilleri-Bernnan’s study demonstrated that 
the gastrointestinal symptoms of  the stoma patients 
became improving since the 3rd postoperative month, 
which was consistent with our results[10]. Schmidt C 
E[11] also proved that the scores of  QOL were much 
lower than the baseline’s level in the early postoperative 
periods. He also illustrated that the global health and 
QOL, emotional function and physical function had 
improved since the 3rd month, and it needed two years 
for nausea and vomiting, agrypnia, constipation and 
diarrhea to restore to the baseline’s level. However, in our 
study, the agrypnia had already restored to the baseline’s 
level in the 6th postoperative month in with permanent 
colostomy, while the constipation and diarrhea continued 
to exist with no significant improvement. This may 
result from the different physical qualities and people’s 
understanding of  social culture. It is clearly seen from 
Lian L’s study[12] that the global QOL, physiological 
function, role function, cognitive function, emotional 
function and social function improved significantly in 
the 3rd postoperative month but which didn’t continue 
afterwards. Some dimensions, such as micturition 
symptoms, gastrointestinal symptoms, stoma-related 
problems, weight loss and chemotherapy side effects 
and so on had relieved gradually during the 6 months 
following surgery. However, in contrast, fatigue, pain, 
dyspnea, sleep disturbance and appetite loss became 
worse. In our study, unlike the body image and future 
perspective, the dimensions of  fatigue, pain, dyspnea, 
sleep disturbance and appetite loss became better in 
the postoperative periods, which is different to those 
of  Lian L’s study. But the results of  the dimensions 
of  micturition symptoms, gastrointestinal symptoms, 
stoma-related problems, weight loss and chemotherapy 
side effects in our study were in consistent with Zhang’s 
study. Besides, his study didn’t ascertain the time for 
the dimensions to restore to the preoperative level as 
a result of  lack of  the baseline’s level. Patients without 
permanent colostomy had relatively higher quality of  
life than that of  patients with permanent colostomy, 
might be explained by the fact that the impact of  the 
permanent colostomy on their life.
Except for constipation, diarrhea, weight loss and 
financial difficulties, all the scores of  pre-operative 
symptoms in patients with permanent colostomy were 
close to the normal reference values of  EORTC QLQ-
C30.
Early colorectal cancer produces no obvious 
symptoms until the tumors breaks into the ulceration[13]. 
There were mainly three aspects of  symptoms[14]: the 
first aspect is the irritative symptom of  rectum, which 
was manifested as frequent awareness of  defecation, 
the change in bowel habit, tenesmus and incomplete 
evacuation. The second aspect is the stenosis of  bowel 
symptom, which was manifested as narrow stools, and 
the malignant obstruction could lead to the constipation 
and difficult defecation. The last aspect was the tumor-
breaking infection symptom, which was manifested as 
mucus per rectum, bloody stool and even the bloody 
purulent stool with obvious weight loss resulting from 
the tumor consumption. Diarrhea, constipation or 
difficult defecation, bloody purulent stool and weight 
loss were the main reasons for patients’ hospitalization. 
In our study, the higher scores of  the dimensions of  
constipation and diarrhea of  patients with permanent 
colostomy in the preoperative periods were caused by 
the cancer itself. As for the high scores of  financial 
difficulties, it might be associated with the local economy 
and the medical insurance system.
At  the1st  postoperative month, the QOL of  patients 
with permanent colostomy decreased significantly with 
the worse functions and severe symptoms. The diagnosis 
of  rectal cancer and the existence of  permanent 
colostomy had caused great pressure that the patients 
can’t stand, as well as the discomfort which as a result 
of  the postoperative wound pain and chemotherapy. 
The QOL of  patients with permanent colostomy was 
the lowest in this period and had lots of  problems, 
such as pain, micturition, gastrointestinal symptoms, 
stoma-related symptoms, agypnia, appetite loss and so 
forth. The pain, especially, the score of  which was three 
times more than the norm and affected the patients’ 
daily life significantly. The micturition problems 
mainly include urinary incontinence, urinary retention, 
incomplete evacuation and urodynia postoperatively, 
and the dysuria will disappear when the patients restore 
to health. To prevent the stoma complications caused 
by the inexperienced stoma nursing and improve the 
patients’ confidence, the medical staff  should increase 
their interview times, focus on the psychology and stoma 
nursing skills, and teach them the pain management 
knowledge and how to rest and strengthen nutrition 
properly. They should also been informed that the 
frequent micturition and urinary retention are induced 
by the urinary catheter and it will disappear gradually, so 
as to relieve their pressure.
After the 3rd postoperative month, all the function 
dimensions improved evidently: emotional function, 
cognitive function, fatigue, gastrointestinal symptoms 
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and shortness of  breath restored to the baseline’s 
level. However, the chemotherapy side effects, nausea 
and vomiting, pain, micturition problems, agrypnia, 
appetite loss, diarrhea and financial difficulties were 
still worse, among which the chemotherapy, nausea and 
vomiting were the worst because of  the therapy. In our 
study, there were 29 patients (59.2%) that accepted the 
radiotherapy or chemotherapy in the 1st postoperative 
month, with 36 (73.5%) in the 3rd and 36 (73.5%) in 
the 6th postoperative month respectively. The entire 
course of  treatment can be divided into 6 times for 
half  a year and the symptoms were also relieved over 
time. The pain and micturition became better in the 1st 
postoperative month because of  the patients’ recovery, 
the excision of  tumor and the nutritional support 
for patients. Meanwhile, the patients themselves also 
became confident and plucky, accepted the reality and 
returned to society. It is the best time for the medical 
staff  to teach them the stoma-related knowledge and 
encourage them to nurse the stoma independently in 
order that they can master the knowledge regarding the 
complication and conscious defecation methods.
After the 6th postoperative month, the QOL 
of  rectal cancer patients with permanent colostomy 
improved consistently. Most dimensions restored to 
the preoperative level and even some were beyond it. 
Social function and body image still kept worse and 
chemotherapy didn’t restore to the preoperative level 
though it had already become better. At this time, 
constipation and diarrhea were still the problems that 
frustrated the patients the most for the stimulation 
of  tumor, obstruction in pre-operation and excision 
of  anal sphincter in post-operation. Lots of  study 
showed that colonic irrigation was helpful to conscious 
defecation. But in our study, most patients still defecated 
physiologically. This was the main reason why the scores 
of  the two dimensions were higher than the norm. This 
fact suggested us that the medical staff  should introduce 
the colonic irrigation to the patients as soon as possible 
which in order to decrease constipation and diarrhea 
for improving the QOL.
Whether the operation could be successful and the 
financial ability was the main anxieties preoperatively. 
As a result of  the confidential medical insurance 
system, most relatives concealed the reality to the 
patients preoperatively. The patients in our study, for 
example, most of  them only knew it was just a stoma 
operation and had no idea with the diagnosis of  rectal 
cancer and permanent colostomy. As a result, there 
were few patients worrying about the primary disease. 
Nevertheless in the 1st postoperative month, the 
primary disease became the most important anxiety of  
patients, followed by the sacrococcygeal region wound 
and stoma complications. As the patients realized their 
diseases gradually, as well as the radio～chemotherapy, 
they were anxious about the cancer metastasis. 
Meanwhile, they paid great attention to the problem of  
sacrococcygeal region wound since the larger wound 
could cause the severe pain or got infected because of  
the discharge and hospital transfer in advance. So this 
time was also the peak period of  stoma complications. 
The primary disease and conscious defecation were still 
the anxieties in the 3rd and 6th postoperative month, 
for the reason that unconscious defecation and exhaust 
had caused much inconvenience to the patients. Besides, 
the problem of  stoma complications still existed. The 
results above indicated us that the medical staff  should 
make intervention pertinently according to the anxieties 
in different periods. For instance, the medical staff  
should introduce the operation methods or effectiveness 
in pre-operation, and then the knowledge regarding 
primary disease, the higher survival rates of  cancer, the 
guiding of  stoma complications and pain management 
knowledge should be informed to the patients in the 1st 
postoperative month to relieve their stress. Afterwards, 
knowledge on the reasonable diet and colonic irrigation 
should be introduced to the patients. 
The incidence rates of  stoma complications in 
the 1st and 3rd postoperative month were 48.98% 
and 46.94% respectively, and peristomal dermatitis 
was the main complication in both periods. When 
in the 6th postoperative month, the incidence rates 
of  stoma complications in decreased to 40.82%, and 
with parastomal herniation as the main complication. 
Some studies[15, 16] showed that the incidence rates 
of  peristomal dermatitis consistently decreased stenosis 
of  stoma tended to be stable over time whereas the 
rates of  peristomal mucous membrane separation and 
parastomal herniation increased continuously, which 
was in corresponded with ours. Peristomal dermatitis 
includes fecal dermatitis and allergic dermatitis. 
The fecal dermatitis was stimulated by the dejection 
and change of  PH value if  the harmful substances 
penetrate the defense mechanism. The reason why the 
allergic dermatitis occurs was the allergen which can 
induce the allergic reaction, mainly including the stoma 
bags fitting such as belt, underpan and so on[17]. As a 
result, the medical staff  should focus on the peristomal 
dermatitis in the 3rd and 6th postoperative month. 
First of  all, distinguishing the type of  dermatitis plays 
an important role. For the fecal dermatitis, we should 
keep the surrounding of  the stoma dry and clean, wash 
the stoma carefully using warm water other than the 
irritant substance like alcohol. We also should attach 
the underpan with the stoma closely to prevent the 
dejection and intestinal fluid from irritating the skin, 
combined with the use of  the skin protective film and 
stoma skincare powder if  the size of  stoma bags is too 
larger. For allergic dermatitis, it was necessary to change 
the articles for stoma nursing use.
After the 6th postoperative month, the patients 
with permanent colostomy should be informed to avoid 
any action that can induce the increase of  abdominal 
pressure, such as chronic coughing, lifting a heavy 
weight, giving stress on abdomen when changing the 
clinostatism and so forth. At the same time, the stoma 
bags with slight convex underpan should be introduced 
to reduce the increasing of  herniation. Then we should 
consider operating method if  all the measures above are 
ineffective.
Conclusions
The trend of  QOL of  rectal cancer patients with 
permanent colostomy in Xi’an in different operative 
periods showed as “v” type: in the postoperative 1st 
month, the score of  QOL was the lowest with the 
worst functions and the worst symptoms; when in the 
3rd postoperative month, all the dimensions improved 
significantly. As for the 6th postoperative month, 
physical function, role function, emotional function, 
cognitive function, future perspective, global QOL, 
fatigue, nausea and vomiting, pain, micturition problem, 
gastrointestinal symptoms, shortness of  breath, agrypnia 
and appetite loss all restored to the preoperative level 
with obviously improving weight loss and stoma-related 
symptoms. Nevertheless, social function, body image, 
chemotherapy side effects and financial difficulties 
were still below the baseline’s level with the consistent 
constipation and diarrhea. In conclusion, the 1st 
postoperative month is a crucial period for patients’ 
recovery, in which we should pay great attention to the 
problems which regard to the patients’ psychological 
conditions, the prevention and control of  stoma 
complications and the conscious defecation methods. 
It is recommended that the stoma nursing staff  should 
be brought into the medical insurance system that in 
order to reduce the patients’ financial stress.
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